iPSC-Derived Islet Cells for Diabetes Mellitus Treatment

This clinical study focuses on treating diabetes mellitus using a unique approach. It involves the use of islet cells, which are special cells that produce insulin, a hormone that helps regulate blood sugar levels. These islet cells are derived from iPSCs, a type of stem cell that can transform into any cell type in the body. The study aims to help patients with diabetes mellitus, a condition where the body cannot produce enough insulin or use it effectively. The goal is to evaluate if these iPSC-derived islet cells can provide a safe and effective treatment method, potentially improving care for those living with this condition. During the study, participants receive an infusion of the iPSC-derived islet cells. The study is open-label, meaning everyone involved knows about the treatment being used. The primary outcome measured is any adverse events or side effects that may occur. This helps determine the safety of the treatment. The study does not specify a phase, indicating it could be early in the research process.